Rosiglitazone-induced weight gain

Trial Profile

Rosiglitazone-induced weight gain

Phase of Trial: Phase I

Latest Information Update: 24 Oct 2016

At a glance

  • Drugs Rosiglitazone (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Oct 2016 Status changed from recruiting to discontinued due to published data on Rosiglitazone.
    • 19 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top